News and Press Releases

Pharming Group announces U.S. FDA acceptance and Priority Review of supplemental New Drug Application forleniolisib in children with APDS aged 4 to 11 years

If approved, leniolisib will be first and only treatment indicated for children with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency Decision based on positive data from...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: October 1, 2025

Pharming Group N.V. Vondellaan 47 2332 AA Leiden The Netherlands

Five Leading Life Science Organisations Collaborate on Inaugural London Bio-Innovation Week

ELRIG, Life Science Integrates, Life Science Nation, One Nucleus and SLAS will provide delegates with the opportunity for cross-event partnering during London Bio-Innovation week, which runs 1st-5th December, 2025 One...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: October 1, 2025

PACE launches its third funding round today, supporting innovative projects that tackle resistant bacterial infections posing the greatest threat to global health

1 October 2025 -- Alderley Park, UK -- To stay ahead of the escalating antibiotic resistance crisis, we need bold thinking and transformative innovation. According to the World Health Organization...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: October 1, 2025

Rezon Bio launches as a European biologics CDMO combining cost efficiency and digital innovation.

New brand with proven track record – EMA and FDA-audited mirrored-capability sites in Poland provide an accelerated path from development to commercialization 29 September 2025 -- Gdańsk, Poland -- Rezon...

Category: BioManufacturing, Logistics, Manufacturing and Packing, Other, Pharmaceutical
Posted: September 29, 2025

Trzy Lipy 3, Building A 80-172 Gdansk, Poland

Pooled data presented at ERS: nerandomilast monotherapy linked to nominally significant reduction in risk of death in IPF and PPF

A new pooled analysis of the FIBRONEER-IPF and FIBRONEER-ILD trials resulted in a nominally significant reduction in the risk of death by 59% in patients who received 18mg nerandomilast without...

Category: Clinical Trials, Drug Delivery, Drug Discovery, Other, Pharmaceutical
Posted: September 29, 2025

Binger Strasse 173 55216 Ingelheim am Rhein

Leqembi (lecanemab) long-term 36-month open-label extension data from post-hoc sub-group analysis of ApoE ε4 non-carriers and heterozygotes presented at Alzheimer’s disease congress in Switzerland

Clarity AD open-label extension data show three years of continuous lecanemab treatment in apolipoprotein E ε4 (ApoE ε4) non-carrier and heterozygote patients continued to accrue benefit relative to the Alzheimer's...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: September 29, 2025

4-6-10 Koishikawa, Bunkyo-ku, Tokyo 112-8088, Japan

Clinigen to Acquire SSI Strategy, Charting a Seamless Path from Clinical Strategy to Global Commercialisation for Biotech Innovators

29 September 2025 -- London, UK -- Clinigen, the global pathfinder accelerating patient access to critical medicines across the lifecycle, today announced it has entered into a definitive agreement to...

Category: Biotechnology, Logistics, Other, Pharmaceutical
Posted: September 29, 2025

25 Bedford Square Bloomsbury London WC1B 3HH

Chiesi Completes Clinical Development Program for Carbon-Minimal Pressurized Metered-Dose Inhalers (pMDIs), Paving the Way for Regulatory Submissions

Successfully completed the TRECOS Phase III study, supporting the long-term safety of Chiesi’s carbon minimal pressurized metered dose inhaler (pMDI) platform Aiming to become the first pharmaceutical company to transition...

Category: Clinical Trials, Drug Delivery, Other, Pharmaceutical
Posted: September 26, 2025

333 Styal Road Manchester M22 5LG United Kingdom

Lonza’s Synaffix Collaborates with Qurient Therapeutics to Enable Development of Dual-Payload ADC

License agreement centered around technology enabling dual-payload ADC Unique combination of Synaffix’s exatecan-based technology with Qurient’s CDK7 inhibitor. 25 September 2025 -- Amsterdam, The Netherlands and Seongnam-Si, Korea -- Synaffix B.V.,...

Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: September 25, 2025

Pivot Park, Curie Building Kloosterstraat 9 5349 AB Oss The Netherlands

Topa Thermal Launches “Cold Chain Tips Series 2” for Pharma Logistics

New 60-second video series delivers practical guidance for temperature-sensitive pharmaceutical shipping Topa Thermal launches “Cold Chain Tips Series 2,” a 60-second video series for pharmaceutical logistics professionals. Episodes deliver practical...

Category:
Posted: September 24, 2025

Torenlaan 10, 2215 RW Voorhout, The Netherlands

CPHI 2025: BENEO to present galenIQ™ as the granulation binder of choice

Mannheim, Germany - September 2025 – At this year’s CPHI Europe in Frankfurt (28–30 October), BENEO will showcase the latest advancements in granulation with its pharmaceutical-grade isomalt excipient: galenIQ™. Visitors...

Category:
Posted: September 24, 2025

Maximilianstrasse 10, 68165 Mannheim, Germany

eXmoor Pharma and Siam Bioscience form strategic partnership to establish leading Cell and Gene Therapy services in Southeast Asia

23 September 2025 -- Bristol, UK and Bangkok, Thailand -- eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, and Siam Bioscience, a leading biopharmaceutical company...

Category: BioManufacturing, Manufacturing and Packing, Other, Pharmaceutical
Posted: September 23, 2025

Britannia Road, Patchway, Bristol, BS34 5TA

OKYO Pharma Announces Registration Pathway with 100 Patient Multi-Center Clinical Trial of Urcosimod in Neuropathic Corneal Pain

22 September 2025 -- London, UK and New York, US -- OKYO Pharma Limited, an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: September 22, 2025

OKYO Pharma Floor 4, 14/15 Conduit St London W1S 2XJ

electronRx to Launch pDx App for Remote Chronic Respiratory Disease Management

Technology detects digital biomarkers to help monitor lung function and optimise therapeutic outcomes for patients electronRx to showcase pDx at HLTH 2025 (19–22 Oct, Las Vegas). 18 September 2025 --...

Category: Other, Pharmaceutical
Posted: September 18, 2025

Eagle Labs, 28 Chesterton Rd, Cambridge CB4 3AZ

Teknomek launches new laboratory furniture range

17 September 2025 - Teknomek, the UK’s leading manufacturer and supplier of hygienic furniture and equipment, has launched a brand-new furniture range for laboratories.  Manufactured from mild steel, with white...

Category: Manufacturing and Packing
Posted: September 17, 2025

Brunel Way, Sweetbriar Industrial Estate, Norwich, Norfolk NR3 2BD